HYVET Study results: importance for clinical practice
HYVET Study was aimed at assessing the effects of indapamide SR (1,5 mg/d), as monotherapy or combined with an ACE inhibitor perindopril (2-4 mg/d), compared to placebo, on the risk of stroke and other cardiovascular events in arterial hypertension patients aged over 80 years. Active indapamide SR t...
Main Author: | S. V. Nedogoda |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2008-10-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1259 |
Similar Items
-
HYVET: landmark trial voted 2008 Trialof the Year by the ImpACT/Society for Clinical Trials and the American Heart Association
by: - -
Published: (2009-06-01) -
Diuretics in arterial hypertension: angels and demons
by: S. V. Nedogoda
Published: (2013-06-01) -
Indapamide retard as the medication of choice in elderly patients with arterial hypertension
by: I. I. Chukaeva, et al.
Published: (2013-10-01) -
Open, multi-center randomized research and clinical program MINOTAUROS: intermediate data analysis
by: I. E. Chazova, et al.
Published: (2006-04-01) -
Long-term indapamide retard therapy in adolescents with Stage I arterial hypertension
by: I. V. Logacheva, et al.
Published: (2011-04-01)